JLCAX
Price
$23.66
Change
-$0.21 (-0.88%)
Updated
Jul 13 closing price
Net Assets
3.7B
VSMPX
Price
$337.67
Change
-$2.70 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

JLCAX vs VSMPX

JLCAX vs VSMPX Comparison Chart in %
View a ticker or compare two or three
VS
JLCAX vs. VSMPX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JLCAX is a Buy and VSMPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 2.3T vs. JLCAX (3.7B). VSMPX pays higher dividends than JLCAX: VSMPX (1.06) vs JLCAX (0.00). JLCAX was incepted earlier than VSMPX: JLCAX (21 years) vs VSMPX (11 years). JLCAX (1.94) is less costly to investors than VSMPX (0.02). JLCAX is a more actively managed with annual turnover of: 100.00 vs. VSMPX (3.00). JLCAX has a lower initial minimum investment than VSMPX: JLCAX (1000) vs VSMPX (100000000). VSMPX annual gain was more profitable for investors over the last year : 21.48 vs. JLCAX (12.65). VSMPX return over 5 years is better than : 66.52 vs. JLCAX (-12.94).
JLCAXVSMPXJLCAX / VSMPX
Total Expense Ratio1.640.028,200%
Annual Report Gross Expense Ratio1.940.029,700%
Fund Existence21 years11 years-
Gain YTD7.81411.20670%
Front Load5%N/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.7B2.3T0%
Annual Yield % from dividends0.001.06-
Returns for 1 year12.6521.4859%
Returns for 3 years39.6067.0359%
Returns for 5 years-12.9466.52-19%
Returns for 10 years-11.12239.43-5%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGSNX21.35N/A
N/A
Vanguard Real Estate Index Institutional
PCAOX91.03N/A
N/A
Principal Capital Appreciation R3
GARIX23.88N/A
N/A
Gotham Absolute Return Institutional
RLAIX24.27N/A
N/A
T. Rowe Price Latin America I
MCYCX15.72-0.49
-3.02%
NYLI Candriam Emerging Markets Eq Cl C